Tg(VIPR2/Hspa1b-cre/ERT2)17Dlee
Transgene Detail
|
|
| Symbol: |
Tg(VIPR2/Hspa1b-cre/ERT2)17Dlee |
| Name: |
transgene insertion 17, Daekee Lee |
| MGI ID: |
MGI:6727072 |
| Synonyms: |
VIPR2-ERT2CreERT2-017 |
| Transgene: |
Tg(VIPR2/Hspa1b-cre/ERT2)17Dlee Location: unknown
|
| Alliance: |
Tg(VIPR2/Hspa1b-cre/ERT2)17Dlee page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(VIPR2/Hspa1b-cre/ERT2)17Dlee expression driven by
1 gene
Transgene expression driven by:
| Organism |
Driver Gene |
Homolog in Mouse |
Note |
| human |
VIPR2 (7434) |
|
|
|
| |
|
Mutation details: A transgene consisting of hs1753 (chr7:158,888,320-158,891,362) enhancer element located in intron 4 of human VIPR2 gene subcloned into Hsp68 promoter fused with ERT2CreERT2-pA to drive expression of cre in response to tamoxifen in developing heart. A total of nine transgenic founders lines 1, 17, 20, 22, 23, 29, 30, 32, 33 were obtained. All transgenic lines showed heart-specific cre activity when bred to a cre reporter mouse.
(J:297289)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
VIPR2
(human)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:297289 Chin HJ, et al., Tamoxifen-inducible cardiac-specific Cre transgenic mouse using VIPR2 intron. Lab Anim Res. 2020;36:31 |
| All: |
1 reference(s) |
|
Analysis Tools
